Genpact LTD is 2.0x more valuable than EXPONENT INC by market capitalization ($5.46 B vs $2.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | G | EXPO |
|---|---|---|
| Market cap | $5.46 B | $2.69 B |
| US-listed rank | #1323 | #1894 |
| Revenue (latest FY) | $5.08B | $582.01M |
| Net income (latest FY) | $552.49M | $106.01M |
| Net margin | 10.9% | 18.2% |
| P/E (trailing FY) | 9.9 | 25.3 |
| SEC filings | 1,502 | 2,029 |
Genpact LTD is 2.0x more valuable than EXPONENT INC by market capitalization ($5.46 B vs $2.69 B).
In their latest fiscal years, Genpact LTD reported $5.08B in revenue while EXPONENT INC reported $582.01M.
Full pages: Genpact LTD and EXPONENT INC, or browse the full rankings.